Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:2495-2501
Published online before print October 13, 2005, doi: 10.1161/01.ATV.0000190610.63878.20
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
25/12/2495    most recent
01.ATV.0000190610.63878.20v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nanami, M.
Right arrow Articles by Nakanishi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nanami, M.
Right arrow Articles by Nakanishi, T.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:2495.)
© 2005 American Heart Association, Inc.


Vascular Biology

Tumor Necrosis Factor-{alpha}–Induced Iron Sequestration and Oxidative Stress in Human Endothelial Cells

Masayoshi Nanami; Tomomi Ookawara; Yoshinaga Otaki; Katsukiyo Ito; Rintarou Moriguchi; Koji Miyagawa; Yukiko Hasuike; Masaaki Izumi; Hironobu Eguchi; Keiichiro Suzuki; Takeshi Nakanishi

From the Department of Internal Medicine, Division of Kidney and Dialysis (M.N., Y.O., K.I., R.M., K.M., Y.K., M.I., T.N.) and the Department of Biochemistry (T.O., H.E., K.S.), Hyogo College of Medicine, Hyogo, Japan.

Correspondence to Masayoshi Nanami, Department of Internal Medicine, Division of Kidney and Dialysis, Hyogo College of Medicine, 1-1 Mukogawa-cho, Hyogo 663-8501, Japan. E-mail m-nanami{at}hyo-med.ac.jp

Objective— Tumor necrosis factor (TNF)-{alpha}–induced endothelial injury, which is associated with atherosclerosis, is mediated by intracellular reactive oxygen species. Iron is essential for the amplification of oxidative stress. We tested whether TNF-{alpha} accelerated iron accumulation in vascular endothelium, favoring synthesis of hydroxyl radical.

Methods and Results— Diverse iron transporters, including iron import proteins (transferrin receptor [TfR] and divalent metal transporter 1 [DMT1]) and an iron export protein (ferroportin 1 [FP1]) coexist in human umbilical endothelial cells (HUVECs). TNF-{alpha} caused upregulation of TfR and DMT1 and downregulation of FP1, which were demonstrated in mRNA as well as protein levels. These changes in iron transporters were accompanied by accumulation of iron that was both transferrin-dependent and transferrin-independent. Modifications of these mRNAs were regulated post-transcriptionally, and were coordinated with activation of binding activity of iron regulatory protein 1 to the iron responsive element on transporter mRNAs. Using a salicylate trap method, we observed that only simultaneous exposure of endothelial cells to iron and TNF-{alpha} accelerated hydroxyl radical production.

Conclusions— TNF-{alpha} could cause intracellular iron sequestration, which may participate importantly in the pathophysiology of atherosclerosis and cardiovascular disease.

TNF-{alpha} induced upregulation of iron import proteins and downregulation of iron export protein in human endothelial cells via a posttranscriptional mechanism. These modifications could cause accumulation of iron in endothelium, increasing oxidative stress that might contribute importantly to the pathophysiologic processes of atherosclerosis.


Key Words: cytokines • endothelium • free radicals • inflammation • iron




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Salazar, N. Mena, S. Hunot, A. Prigent, D. Alvarez-Fischer, M. Arredondo, C. Duyckaerts, V. Sazdovitch, L. Zhao, L. M. Garrick, et al.
Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease
PNAS, November 25, 2008; 105(47): 18578 - 18583.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. l. Sullivan
Macrophage Iron, Hepcidin, and Atherosclerotic Plaque Stability
Experimental Biology and Medicine, September 1, 2007; 232(8): 1014 - 1020.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Constante, D. Wang, V.-A. Raymond, M. Bilodeau, and M. M. Santos
Repression of Repulsive Guidance Molecule C during Inflammation Is Independent of Hfe and Involves Tumor Necrosis Factor-{alpha}
Am. J. Pathol., February 1, 2007; 170(2): 497 - 504.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Li and B. Frei
Iron Chelation Inhibits NF-{kappa}B-Mediated Adhesion Molecule Expression by Inhibiting p22phox Protein Expression and NADPH Oxidase Activity
Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2638 - 2643.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Stocker and M. A. Perrella
Heme Oxygenase-1: A Novel Drug Target for Atherosclerotic Diseases?
Circulation, November 14, 2006; 114(20): 2178 - 2189.
[Full Text] [PDF]